Drug Type Small molecule drug |
Synonyms Cushing’s disease program (LifeArc) |
Target |
Action antagonists |
Mechanism MRAP2 antagonists(melanocortin 2 receptor accessory protein 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cushing Syndrome | Preclinical | United Kingdom | 18 May 2012 |